To date, a number of studies have investigated the association between aberrant methylation of RASSF1A and HNSCC through a comparison of the methylation prevalence of RASSF1A between cancerous tissues and controls. The gene discussed is RASSF1; the disease is head and neck squamous cell carcinoma.